Thermo Fisher finally lands Qiagen with $11.5B deal

After months of a public back-and-forth over a potential acquisition, Thermo Fisher Scientific President and CEO Marc Casper said he and Qiagen’s leadership finally had a “meeting of the minds” on how to move forward—and $11.5 billlion later, they’ve set a target date for the first half of 2021.

Sourced through Scoop.it from: www.fiercebiotech.com